Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 226

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Human CD14+CTLA-4+ Regulatory Dendritic Cells Suppress T-Cell Response by Cytotoxic T-Lymphocyte Antigen-4-Dependent IL-10 and Indoleamine-2,3-Dioxygenase Production in Hepatocellular Carcinoma

Open access
Han, Yanmei, Chen, Zhubo, Yang, Yuan, Jiang, Zhengping, Gu, Yan, Liu, Yangfang, Lin, Chuan, Pan, Zeya, Yu, Yizhi, Jiang, Minghong, Zhou, Weiping, Cao, Xuetao · 2014 · Hepatology

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with limited therapeutic options. HCC-induced immunosuppression often leads to ineffectiveness of immuno-promoting therapies. Currently, suppressing the suppressors has become the potential strategy for cancer immunotherapy. So, figuring out the immunosuppressive mechanisms induced and employed by HCC will be helpful to the design and application of HCC immunotherapy. Here, we identified one new subset of human CD14+CTLA-4+ regulatory dendritic cells (CD14+DCs) in HCC patients, representing ˜13% of peripheral blood mononuclear cells. CD14+DCs significantly suppress T-cell response in vitro through interleukin (IL)-10 and indoleamine-2,3-dioxygenase (IDO). Unexpectedly, CD14+DCs expressed high levels of cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1, and CTLA-4 was found to be essential to IL-10 and IDO production. So, we identified a novel human tumor-induced regulatory DC subset, which suppresses antitumor immune response through CTLA-4-dependent IL-10 and IDO production, thus indicating the important role of nonregulatory T-cell-derived CTLA-4 in tumor-immune escape or immunosuppression. Conclusions : These data outline one mechanism for HCC to induce systemic immunosuppression by expanding CD14+DCs, which may contribute to HCC progression. This adds new insight to the mechanism for HCC-induced immunosuppression and may also provide a previously unrecognized target of immunotherapy for HCC. (Hepatology 2014;59:567–579)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.26694

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 36

  1. Rabinovich, 2007, Immunosuppressive strategies that are mediated by tumor cells., Annu Rev Immunol, 25, 267, 10.1146/annurev.immunol.25.022106.141609 · DOI · Paper page
  2. Zou, 2006, Regulatory T cells, tumour immunity and immunotherapy., Nat Rev Immunol, 6, 295, 10.1038/nri1806 · DOI · Paper page
  3. Wang, 2007, Regulatory T cells and cancer., Curr Opin Immunol, 19, 217, 10.1016/j.coi.2007.02.004 · DOI · Paper page
  4. Vignali, 2008, How regulatory T cells work., Nat Rev Immunol, 8, 523, 10.1038/nri2343 · DOI · Paper page
  5. von Boehmer, 2005, Mechanisms of suppression by suppressor T cells., Nat Immunol, 6, 338, 10.1038/ni1180 · DOI · Paper page
  6. Han, 2009, CD69CD4CD25 T cells, a new subset of regulatory T cells, suppress T cell proliferation through membranebound TGF1., J Immunol, 182, 111, 10.4049/jimmunol.182.1.111 · DOI · Paper page
  7. Mantovani, 2010, Macrophages, innate immunity and cancer: balance, tolerance, and diversity., Curr Opin Immunol, 22, 231, 10.1016/j.coi.2010.01.009 · DOI · Paper page
  8. Auffray, 2009, Blood monocytes: development, heterogeneity, and relationship with dendritic cells., Annu Rev Immunol, 27, 669, 10.1146/annurev.immunol.021908.132557 · DOI · Paper page
  9. Ueno, 2010, Harnessing human dendritic cell subsets for medicine., Immunol Rev, 234, 199, 10.1111/j.0105-2896.2009.00884.x · DOI · Paper page
  10. Bachem, 2010, Superior antigen crosspresentation and XCR1 expression define human CD11cCD141 cells as homologues of mouse CD8 dendritic cells., J Exp Med, 207, 1273, 10.1084/jem.20100348 · DOI · Paper page
  11. Kassianos, 2012, Human CD1c (BDCA1) myeloid dendritic cells secrete IL10 and display an immunoregulatory phenotype and function in response to Escherichia coli., Eur J Immunol, 42, 1512, 10.1002/eji.201142098 · DOI
  12. Qian, 2012, Naturally occurring CD1c human regulatory dendritic cells: immunoregulators that are expanded in response to E. coli infection., Eur J Immunol, 42, 1388, 10.1002/eji.201242632 · DOI
  13. Bamboat, 2009, Human liver dendritic cells promote T cell hyporesponsiveness., J Immunol, 184, 1901, 10.4049/jimmunol.0803404 · DOI · Paper page
  14. Chu, 2012, Resident CD141 (BDCA3) dendritic cells in human skin produce IL10 and induce regulatory T cells that suppress skin inflammation., J Exp Med, 209, 935, 10.1084/jem.20112583 · DOI · Paper page
  15. Morel, 2011, Dendritic cells and the maintenance of selftolerance., Immunol Res, 50, 124, 10.1007/s12026-011-8217-y · DOI
  16. Yogev, 2012, Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD1 receptor regulatory T cells., Immunity, 37, 264, 10.1016/j.immuni.2012.05.025 · DOI · Paper page
  17. Liu, 2009, Tumoreducated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I., J Immunol, 182, 6207, 10.4049/jimmunol.0803926 · DOI · Paper page
  18. Breous, 2011, Potential of immunotherapy for hepatocellular carcinoma., J Hepatol, 54, 830, 10.1016/j.jhep.2010.10.013 · DOI
  19. Zhou, 2009, Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients., Int J Cancer, 125, 1640, 10.1002/ijc.24556 · DOI · Paper page
  20. Li, 2009, Cancerexpanded myeloidderived suppressor cells induce anergy of NK Cells through membranebound TGF1., J Immunol, 182, 240, 10.4049/jimmunol.182.1.240 · DOI · Paper page
  21. Grossman, 2004, Human T regulatory cells can use the perforin pathway to cause autologous target cell death., Immunity, 21, 589, 10.1016/j.immuni.2004.09.002 · DOI · Paper page
  22. Xia, 2008, Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance., Blood, 112, 3175, 10.1182/blood-2008-05-159921 · DOI
  23. Agrawal, 2006, ERK1 mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis., J Immunol, 176, 5788, 10.4049/jimmunol.176.10.5788 · DOI
  24. Kaiser, 2009, TPL2 negatively regulates interferon production in macrophages and myeloid dendritic cells., J Exp Med, 206, 1863, 10.1084/jem.20091059 · DOI · Paper page
  25. Pizzolla, 2011, CD68expressing cells can prime T cells and initiate autoimmune arthritis in the absence of reactive oxygen species., Eur J Immunol, 41, 403, 10.1002/eji.201040598 · DOI
  26. Saraiva, 2010, The regulation of IL10 production by immune cells., Nat Rev Immunol, 10, 170, 10.1038/nri2711 · DOI · Paper page
  27. Mauri, 2012, Immune regulatory function of B cells., Annu Rev Immunol, 30, 221, 10.1146/annurev-immunol-020711-074934 · DOI · Paper page
  28. Munn, 2007, Indoleamine 2,3dioxygenase and tumorinduced tolerance., J Clin Invest, 117, 1147, 10.1172/JCI31178 · DOI · Paper page
  29. Katz, 2008, Indoleamine 2,3dioxygenase in Tcell tolerance and tumoral immune escape., Immunol Rev, 222, 206, 10.1111/j.1600-065X.2008.00610.x · DOI · Paper page
  30. Vignali, 2008, How regulatory T cells work., Nat Rev Immunol, 8, 523, 10.1038/nri2343 · DOI · Paper page
  31. Fallarino, 2003, Modulation of tryptophan catabolism by regulatory T cells., Nat Immunol, 4, 1206, 10.1038/ni1003 · DOI · Paper page
  32. File, 2008, Control of peripheral Tcell tolerance and autoimmunity via the CTLA4 and PD1 pathways., Immunol Rev, 224, 166, 10.1111/j.1600-065X.2008.00662.x · DOI · Paper page
  33. Wing, 2008, CTLA4 control over Foxp3 regulatory T cell function., Science, 322, 271, 10.1126/science.1160062 · DOI · Paper page
  34. Friedline, 2009, CD4 regulatory T cells require CTLA4 for the maintenance of systemic tolerance., J Exp Med, 206, 421, 10.1084/jem.20081811 · DOI · Paper page
  35. Hodi, 2010, Improved survival with ipilimumab in patients with metastatic melanoma., N Engl J Med, 363, 711, 10.1056/NEJMoa1003466 · DOI · Paper page
  36. Munn, 2004, Ligation of B7-1B7-2 by human CD4 T cells triggers indoleamine 2,3dioxygenase activity in dendritic cells., J Immunol, 172, 4100, 10.4049/jimmunol.172.7.4100 · DOI · Paper page

Cited by

See all 226

Metadata

Authors
Han, Y., Chen, Z., Yang, Y., Jiang, Z., Gu, Y., Liu, Y., Lin, C., Pan, Z., Yu, Y., Jiang, M., Zhou, W., & Cao, X.
Venue
Hepatology
Published
2014-02
Volume
59
Issue
2
Pages
567-579
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2153267053
Cited by
226
References
5
FWCI
6.29
Type
journal article
Language
en
Open access
bronze
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 577 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human CD14+CTLA-4+ Regulatory Dendritic Cells Suppress T-Cell Response by Cytotoxic T-Lymphocyte Antigen-4-Dependent IL-10 and Indoleamine-2,3-Dioxygenase Production in Hepatocellular Carcinoma. https://app.cochat.ai/papers/10.1002/hep.26694
The paper
Han, Y., Chen, Z., Yang, Y., Jiang, Z., Gu, Y., Liu, Y., Lin, C., Pan, Z., Yu, Y., Jiang, M., Zhou, W., & Cao, X. (2014). Human CD14+CTLA-4+ Regulatory Dendritic Cells Suppress T-Cell Response by Cytotoxic T-Lymphocyte Antigen-4-Dependent IL-10 and Indoleamine-2,3-Dioxygenase Production in Hepatocellular Carcinoma. Hepatology. https://doi.org/10.1002/hep.26694

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.